Considering that mitochondrial calcium overload triggered by RIPK1 activation precedes the DCM-associated phenotype, we explored whether RIPK1 inhibitors could potentially halt the progression of DCM and HF phenotypes in TAB2-knockout cardiomyocytes. The gene discussed is TAB2; the disease is familial dilated cardiomyopathy.